Studies found no heterogeneity of GLP1-RA relative treatment effect by age118, blood pressure119,120, diabetes duration121, history of cardiovascular disease/heart failure119,122 or use of RAS inhibitors119. Here, GLP1R is linked to cardiovascular disorder.